Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph phase_4
2
18%
Ph phase_3
4
36%
Ph not_applicable
4
36%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
4(36.4%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(7)
Other(4)

Detailed Status

Completed7
unknown4

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 34 (36.4%)
Phase 42 (18.2%)
N/A4 (36.4%)

Trials by Status

completed764%
unknown436%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11